Trump CBD Reimbursement Program Stalls Ahead Of Federal Hemp Ban
Patients in New York and Florida started receiving products in May
Six months after the launch of a Trump administration program that promised seniors free hemp-derived CBD products, the effort appears stalled in large part because of the looming federal ban on most hemp cannabinoid products.
Only six “accountable care organizations” – networks of doctors and hospitals that share care and costs for a group of Medicare patients – out of 74 in the U.S. are approved to offer hemp CBD products, a spokesperson for the federal Centers for Medicare & Medicaid Services told MJBizDaily. And CMS did not say how many of the six are giving products to patients.
Patients in New York and Florida started receiving products in May. But none of the hemp companies lined up to supply the program has reported revenue from it, according to an MJBizDaily review of public filings.
Frustrated would-be suppliers and hemp advocates say the Substance Access Beneficiary Engagement Incentive, embraced by President Donald Trump and CMS Administrator Mehmet Oz thanks to the efforts of a Mar-a-Lago Club member, is dead on arrival until Congress makes sure products can stay on shelves after Dec. 11.
To Read The Rest Of This Article On MJ Biz Daily, Click Here
